Literature DB >> 2386379

Nephrotoxicity after ifosfamide.

R Skinner1, A D Pearson, L Price, M G Coulthard, A W Craft.   

Abstract

Eleven children and adolescents with previously normal renal function who received ifosfamide for the treatment of extrarenal solid tumours underwent detailed investigation of glomerular and renal tubular function to assess the incidence and extent of renal damage. None had received cisplatin. Glomerular filtration rate (measured by plasma clearance of 51Cr labelled edetic acid) was reduced in six children. All 11 patients had evidence of proximal, and six of distal, tubular damage. Proximal tubular toxicity was indicated by phosphaturia and hypophosphataemia (n = 4), glycosuria (n = 5), increased urine beta 2 microglobulin excretion (n = 11), and generalised aminoaciduria (n = 10); distal tubular damage caused a reduction of the osmolality of the urine in an early morning sample. Two children developed clinical hypophosphataemic rickets, and one of these also had severe nephrogenic diabetes insipidus. Glomerular and tubular nephrotoxicity are common and potentially serious complications of ifosfamide treatment in children.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2386379      PMCID: PMC1792439          DOI: 10.1136/adc.65.7.732

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  33 in total

1.  Ifosfamide-induced renal tubular defects.

Authors:  W P Patterson; A Khojasteh
Journal:  Cancer       Date:  1989-02-15       Impact factor: 6.860

2.  Fanconi syndrome after ifosfamide.

Authors:  M Moncrieff; A Foot
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 3.  Nephrotoxicity of antitumoral agents.

Authors:  J P Fillastre; G Viotte; J P Morin; B Moulin
Journal:  Adv Nephrol Necker Hosp       Date:  1988

4.  Urinary protein and enzyme excretion in patients receiving chemotherapy with the cis-platinum analogs carboplatin (CBDCA, JM8) and iproplatin (CHIP, JM9).

Authors:  A W Skillen; P K Buamah; B M Cantwell; C Cornell; A W Hodson; A L Harris
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 5.  Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation.

Authors:  R A Branch
Journal:  Arch Intern Med       Date:  1988-11

6.  Acyclovir-induced renal failure. Clinical course and histology.

Authors:  M H Sawyer; D E Webb; J E Balow; S E Straus
Journal:  Am J Med       Date:  1988-06       Impact factor: 4.965

7.  Nephrotoxicity associated with ifosfamide.

Authors:  J Smeitink; M Verreussel; C Schröder; R Lippens
Journal:  Eur J Pediatr       Date:  1988-11       Impact factor: 3.183

8.  A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people.

Authors:  I Magrath; J Sandlund; A Raynor; S Rosenberg; V Arasi; J Miser
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Investigations into negative interference by jaundiced plasma in kinetic Jaffé methods for plasma creatinine determination.

Authors:  M L Knapp; O Hadid
Journal:  Ann Clin Biochem       Date:  1987-01       Impact factor: 2.057

10.  Phenotypically deficient urinary elimination of carboxyphosphamide after cyclophosphamide administration to cancer patients.

Authors:  A H Hadidi; C E Coulter; J R Idle
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

View more
  27 in total

Review 1.  Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.

Authors:  K L Dechant; R N Brogden; T Pilkington; D Faulds
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

2.  Iphosphamide-induced nephrotoxicity in children.

Authors:  R Shore; M Greenberg; D Geary; G Koren
Journal:  Pediatr Nephrol       Date:  1992-03       Impact factor: 3.714

Review 3.  Biomarkers of Drug-Induced Kidney Toxicity.

Authors:  Benjamin R Griffin; Sarah Faubel; Charles L Edelstein
Journal:  Ther Drug Monit       Date:  2019-04       Impact factor: 3.681

Review 4.  Renal toxicity and chemotherapy in children with cancer.

Authors:  Antonio Ruggiero; Pietro Ferrara; Giorgio Attinà; Daniela Rizzo; Riccardo Riccardi
Journal:  Br J Clin Pharmacol       Date:  2017-09-20       Impact factor: 4.335

Review 5.  Renal tubular acidosis secondary to capecitabine, oxaliplatin, and cetuximab treatment in a patient with metastatic colon carcinoma: a case report and review of the literature.

Authors:  Amir Sonnenblick; Amichay Meirovitz
Journal:  Int J Clin Oncol       Date:  2010-03-10       Impact factor: 3.402

6.  Renal function following unilateral nephrectomy for neuroblastoma and Wilms' tumour.

Authors:  M Schell; P Cochat; A Hadj-Aïssa; E Bouffet; L Dubourg; M Brunat-Mentigny
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

Review 7.  Paediatrics--Part II.

Authors:  B L Priestley; C J Harrison; M P Gerrard; A Gibson
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

8.  Effects of blood purification therapy on a patient with ifosfamide-induced neurotoxicity and acute kidney injury.

Authors:  Hiroaki Nishimura; Hideki Enokida; Satoshi Nagano; Masahiro Yokouchi; Hiroshi Hayami; Setsuro Komiya; Masayuki Nakagawa
Journal:  J Artif Organs       Date:  2013-10-04       Impact factor: 1.731

9.  Partial and complete de Toni-Debré-Fanconi syndrome after ifosfamide chemotherapy of childhood malignancy.

Authors:  R Rossi; J H Ehrich
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Bone metabolism and mineralisation after cytotoxic chemotherapy including ifosfamide.

Authors:  J de Schepper; S Hachimi-Idrissi; O Louis; R Maurus; J Otten
Journal:  Arch Dis Child       Date:  1994-10       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.